Mantovani, L. (2024) “Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy: Results of an Updated Analysis”, Farmeconomia. Health economics and therapeutic pathways, 25(1). doi: 10.7175/fe.v25i1.1568.